NCLEX Review Guide: Pediatric Congestive Heart Failure

Understanding Pediatric CHF

• Pediatric congestive heart failure (CHF) occurs when the heart cannot pump blood efficiently to meet the body's metabolic demands, resulting in insufficient cardiac output and congestion in the pulmonary or systemic circulation. Unlike adult CHF which commonly results from ischemic heart disease, pediatric CHF is primarily caused by congenital heart defects or acquired conditions affecting cardiac structure and function.
• The pathophysiology involves activation of compensatory mechanisms including the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system, leading to fluid retention, increased afterload, and myocardial remodeling which further compromises cardiac function.

Common Causes in Children

• Congenital Heart Defects: Structural abnormalities present at birth, including septal defects (ASD, VSD), patent ductus arteriosus (PDA), coarctation of the aorta, and complex lesions like tetralogy of Fallot or hypoplastic left heart syndrome.
• Cardiomyopathy: Disease of the heart muscle affecting its structure and function, including dilated, hypertrophic, and restrictive types. Viral myocarditis is a common acquired cause in previously healthy children.
• Dysrhythmias: Abnormal heart rhythms that compromise cardiac output, particularly tachyarrhythmias that reduce ventricular filling time.
• Volume Overload Conditions: Conditions that increase preload, including anemia, sepsis, and fluid overload from renal disease.

Infant Presentation

• Infants with CHF typically present with feeding difficulties including fatigue during feeding, diaphoresis, and poor weight gain despite adequate caloric intake. These symptoms occur because feeding requires increased energy expenditure that the compromised heart cannot support.
• Respiratory manifestations include tachypnea (>60 breaths/minute), nasal flaring, retractions, grunting, and crackles/rales on auscultation. Infants may develop a distinctive cardiac cough due to pulmonary congestion.
• Cardiovascular findings include tachycardia (>160 beats/minute at rest), cardiomegaly (enlarged heart), hepatomegaly, and possibly a gallop rhythm on auscultation. Peripheral edema is less common in infants than in older children and adults.

Older Child Presentation

• Older children may report fatigue, exercise intolerance, dyspnea on exertion, and orthopnea. School performance may decline due to chronic fatigue and poor concentration related to decreased cerebral perfusion.
• Physical examination may reveal jugular venous distention (JVD), peripheral edema (especially periorbital and dependent edema), hepatomegaly, and ascites in severe cases. Pulmonary edema manifests as crackles on auscultation and may cause wheezing.
• Growth delays and developmental issues may be present in children with chronic CHF, as energy is diverted from growth to maintain basic cardiac function. Monitoring growth parameters is essential for long-term management.

Laboratory Tests

• B-type Natriuretic Peptide (BNP): Elevated in CHF, this biomarker is released in response to ventricular wall stretch. BNP levels correlate with CHF severity and can be used to monitor treatment response. Normal values in children vary by age, but levels >100 pg/mL warrant further investigation.
• Complete Blood Count (CBC): May reveal anemia (which can exacerbate or cause high-output heart failure) or leukocytosis (suggesting infection or inflammation). Polycythemia may be present in children with cyanotic heart defects.
• Electrolytes and Renal Function: Hyponatremia may occur due to water retention and dilution. BUN and creatinine help assess renal perfusion and function, which may be compromised in severe CHF.
• Liver Function Tests: Elevated liver enzymes (AST, ALT) may indicate hepatic congestion due to right-sided heart failure. Albumin levels may be decreased in chronic CHF.

Imaging and Other Diagnostics

• Chest X-ray: Typically shows cardiomegaly (cardiothoracic ratio >0.5 in infants, >0.45 in children), pulmonary vascular congestion, and possibly pleural effusions. Specific cardiac chamber enlargement may provide clues to the underlying defect.
• Electrocardiogram (ECG): May show tachycardia, chamber enlargement, hypertrophy, strain patterns, or arrhythmias. ST-T wave changes may indicate myocardial strain or ischemia.
• Echocardiography: The gold standard for diagnosing structural heart defects, assessing cardiac function, and determining the cause of CHF. Provides measurements of ejection fraction, fractional shortening, chamber dimensions, and valve function.
• Cardiac Catheterization: May be performed to measure pressures within cardiac chambers, assess oxygen saturation across chambers, evaluate coronary arteries, or perform interventional procedures for certain defects.

Assessment Priorities

• Perform comprehensive cardiovascular assessment including heart rate, rhythm, blood pressure, perfusion (capillary refill, skin color and temperature), and presence of edema. Compare bilateral pulses for strength and equality, which may identify coarctation of the aorta.
• Assess respiratory status including rate, effort, breath sounds, and oxygen saturation. Document presence of retractions, nasal flaring, grunting, or positional preferences that ease breathing.
• Evaluate nutritional status by monitoring weight, intake and output, feeding patterns, and growth parameters. Calculate caloric intake and compare to increased metabolic demands of CHF.
• Assess for signs of activity intolerance, including vital sign changes with activity, fatigue during play or feeding, and developmental milestone achievement.

Pharmacological Management

• Diuretics: Furosemide (Lasix) is most commonly used to reduce preload by promoting sodium and water excretion. Dosing in children is typically 1-2 mg/kg/dose given 1-4 times daily. Monitor for electrolyte imbalances, especially hypokalemia and metabolic alkalosis.
• ACE Inhibitors: Medications like enalapril or captopril reduce afterload by inhibiting the renin-angiotensin-aldosterone system. They improve cardiac output and decrease workload on the heart. Monitor for hypotension, hyperkalemia, and renal function changes.
• Beta-Blockers: Carvedilol or metoprolol may be used to reduce heart rate, myocardial oxygen consumption, and prevent remodeling. These are typically added after stabilization with diuretics and ACE inhibitors.
• Inotropic Agents: Digoxin may be used to increase contractility, though its use has declined. In acute decompensated heart failure, IV inotropes like milrinone or dobutamine may be required.

Nursing Interventions

1. Positioning: Place infant/child in semi-Fowler's or high Fowler's position to decrease pulmonary congestion and ease respiratory effort. For infants, elevate the head of the crib 30-45 degrees.
2. Oxygen Therapy: Administer supplemental oxygen as prescribed to improve tissue oxygenation. Monitor oxygen saturation continuously, maintaining levels >94% unless otherwise indicated.
3. Nutrition Management: For infants, consider concentrated formula (24-27 cal/oz) to provide adequate calories with less volume. Schedule small, frequent feedings to reduce energy expenditure. For breastfed infants, consider supplementation with expressed breast milk that has been fortified.
4. Fluid Management: Monitor intake and output strictly. Implement fluid restrictions if ordered, typically 75-100% of maintenance requirements. Weigh daily at the same time with the same scale.
5. Activity Management: Plan care to allow for rest periods. Cluster nursing activities to minimize energy expenditure. Provide age-appropriate quiet activities.
6. Medication Administration: Administer medications as prescribed, monitoring for therapeutic effects and adverse reactions. Educate parents on medication regimen for home management.

Family Education

• Teach parents/caregivers to recognize signs of worsening CHF including increased respiratory effort, decreased feeding, increased irritability, decreased urine output, and weight gain. Provide clear guidelines on when to contact healthcare providers.
• Demonstrate medication administration techniques, especially for liquid medications that require precise measurement. Review medication schedule, purpose, and potential side effects.
• Educate on nutritional needs, including preparation of concentrated formula if prescribed. Discuss feeding techniques to minimize energy expenditure, such as pacing and frequent burping.
• Provide immunization education, emphasizing the importance of routine vaccinations plus RSV prophylaxis (palivizumab) if indicated. Respiratory infections can significantly worsen CHF in children.

Common Pitfalls in CHF Management

• Mistaking CHF for respiratory infection: Children with CHF often present with respiratory symptoms that may be misdiagnosed as pneumonia or bronchiolitis. The presence of hepatomegaly, feeding difficulties with diaphoresis, and cardiomegaly on chest X-ray help differentiate CHF from primary respiratory conditions.
• Overlooking nutritional needs: The increased metabolic demands of CHF coupled with feeding difficulties can lead to malnutrition. Caloric intake should be optimized while considering fluid restrictions, which may necessitate the use of concentrated formulas.
• Inadequate monitoring of fluid status: Relying solely on intake and output measurements without daily weights can lead to missed fluid overload. Daily weights are essential for accurate assessment of fluid status in pediatric CHF.
• Medication dosing errors: Pediatric medication dosing is weight-based and requires careful calculation. Dosing errors, especially with medications having narrow therapeutic ranges like digoxin, can lead to serious adverse effects.

Priority Setting Questions

• When answering NCLEX questions about pediatric CHF, prioritize interventions addressing airway, breathing, and circulation first. For example, positioning to reduce respiratory distress would take priority over teaching about medication administration.
• Remember that in acute CHF, assessment and interventions for respiratory distress are typically the highest priority, followed by maintaining adequate cardiac output, then addressing fluid and electrolyte balance.
• For chronic CHF management questions, focus on preventing complications, optimizing nutrition, and promoting development while managing the underlying condition.

Application of Nursing Process

• Assessment: NCLEX questions often test your ability to recognize the key assessment findings in pediatric CHF. Remember that presentations differ by age - infants show feeding difficulties and respiratory distress, while older children may report exercise intolerance.
• Nursing Diagnosis: Common nursing diagnoses include decreased cardiac output, ineffective breathing pattern, imbalanced nutrition, activity intolerance, and risk for infection. Be prepared to identify the most appropriate diagnosis based on assessment data.
• Planning/Intervention: Questions may ask about appropriate interventions for specific problems. Remember that interventions should be tailored to the child's age and developmental level.
• Evaluation: Know the expected outcomes of interventions. For example, after diuretic administration, expected outcomes include decreased respiratory distress, decreased edema, and improved urine output.

Study Strategies

• Create comparison charts for left-sided vs. right-sided heart failure, and for CHF vs. respiratory conditions. These distinctions are frequently tested on NCLEX.
• Memorize normal vital sign ranges for different pediatric age groups to better identify abnormal findings in CHF cases.
• Practice calculating pediatric medication doses, especially for common CHF medications like furosemide, ACE inhibitors, and digoxin.
• Review growth and development milestones to understand how CHF might impact normal development and how to adapt care accordingly.

Self-Assessment Checklist

• I can describe the pathophysiology of pediatric CHF and how it differs from adult CHF
• I can identify the common causes of CHF in different pediatric age groups
• I can recognize the clinical manifestations of CHF in infants versus older children
• I understand the diagnostic tests used to confirm pediatric CHF
• I know the major medication classes used in pediatric CHF management and their nursing implications
• I can implement appropriate nursing interventions for a child with CHF
• I can differentiate between CHF and primary respiratory conditions
• I understand how to educate families about CHF management at home
• I can prioritize care for a child with acute versus chronic CHF
• I know the warning signs that indicate worsening of CHF in children